The Klotho gene family and the Endocrine fibroblast growth factors

Hiroshi Kurosu, Makoto Kuro-O

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Purpose of review This review summarizes recent progress in understanding of Klotho and βKlotho function in the regulation of tissue-specific metabolic activity of the endocrine fibroblast growth factors (FGF19, FGF21, and FGF23). Recent findings The Klotho gene encodes a single-pass transmembrane protein and functions as an aging-suppressor gene, which extends lifespan when overexpressed and accelerates the development of aging-like phenotypes when disrupted in mice. FGF23 is a bone-derived hormone that regulates phosphate and vitamin D metabolism. It has been shown that Klotho-deficient mice and FGF23 knockout mice exhibit identical phenotypes. This observation led to the identification of Klotho as a cofactor essential for the interaction between FGF23 and fibroblast growth factor receptors. In addition to the Klotho- FGF23 axis, recent studies have shown that βKlotho, a Klotho family protein, also functions as a cofactor required for FGF19 and FGF21 signaling and determines tissue-specific metabolic activities of FGF19 and FGF21. Recent mouse genetic studies have broadened our understanding of molecular pathways involved in mineral and bile acid homeostasis regulated by FGF23 and FGF19, respectively. The FGF19 subfamily of ligands requires the Klotho gene family of transmembrane proteins for their tissue-specific bioactivity. Further investigations on endocrine axes mediated by the Klotho family and FGF19 subfamily members are expected to provide new insights into the molecular mechanisms by which the endocrine fibroblast growth factors regulate bile acid, energy, and phosphate/vitamin D metabolism.

Original languageEnglish (US)
Pages (from-to)368-372
Number of pages5
JournalCurrent Opinion in Nephrology and Hypertension
Volume17
Issue number4
DOIs
StatePublished - Jul 2008

Fingerprint

Fibroblast Growth Factors
Bile Acids and Salts
Vitamin D
Phosphates
Genes
Suppressor Genes
Phenotype
Fibroblast Growth Factor Receptors
Knockout Mice
Minerals
Proteins
Homeostasis
Hormones
Ligands
Bone and Bones
fibroblast growth factor 21

Keywords

  • ßKlotho
  • FGF15
  • FGF19
  • FGF21
  • FGF23
  • Klotho

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

The Klotho gene family and the Endocrine fibroblast growth factors. / Kurosu, Hiroshi; Kuro-O, Makoto.

In: Current Opinion in Nephrology and Hypertension, Vol. 17, No. 4, 07.2008, p. 368-372.

Research output: Contribution to journalArticle

Kurosu, Hiroshi ; Kuro-O, Makoto. / The Klotho gene family and the Endocrine fibroblast growth factors. In: Current Opinion in Nephrology and Hypertension. 2008 ; Vol. 17, No. 4. pp. 368-372.
@article{c9ce9ec44cd5441daddd2ec5ac707300,
title = "The Klotho gene family and the Endocrine fibroblast growth factors",
abstract = "Purpose of review This review summarizes recent progress in understanding of Klotho and βKlotho function in the regulation of tissue-specific metabolic activity of the endocrine fibroblast growth factors (FGF19, FGF21, and FGF23). Recent findings The Klotho gene encodes a single-pass transmembrane protein and functions as an aging-suppressor gene, which extends lifespan when overexpressed and accelerates the development of aging-like phenotypes when disrupted in mice. FGF23 is a bone-derived hormone that regulates phosphate and vitamin D metabolism. It has been shown that Klotho-deficient mice and FGF23 knockout mice exhibit identical phenotypes. This observation led to the identification of Klotho as a cofactor essential for the interaction between FGF23 and fibroblast growth factor receptors. In addition to the Klotho- FGF23 axis, recent studies have shown that βKlotho, a Klotho family protein, also functions as a cofactor required for FGF19 and FGF21 signaling and determines tissue-specific metabolic activities of FGF19 and FGF21. Recent mouse genetic studies have broadened our understanding of molecular pathways involved in mineral and bile acid homeostasis regulated by FGF23 and FGF19, respectively. The FGF19 subfamily of ligands requires the Klotho gene family of transmembrane proteins for their tissue-specific bioactivity. Further investigations on endocrine axes mediated by the Klotho family and FGF19 subfamily members are expected to provide new insights into the molecular mechanisms by which the endocrine fibroblast growth factors regulate bile acid, energy, and phosphate/vitamin D metabolism.",
keywords = "{\ss}Klotho, FGF15, FGF19, FGF21, FGF23, Klotho",
author = "Hiroshi Kurosu and Makoto Kuro-O",
year = "2008",
month = "7",
doi = "10.1097/MNH.0b013e3282ffd994",
language = "English (US)",
volume = "17",
pages = "368--372",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The Klotho gene family and the Endocrine fibroblast growth factors

AU - Kurosu, Hiroshi

AU - Kuro-O, Makoto

PY - 2008/7

Y1 - 2008/7

N2 - Purpose of review This review summarizes recent progress in understanding of Klotho and βKlotho function in the regulation of tissue-specific metabolic activity of the endocrine fibroblast growth factors (FGF19, FGF21, and FGF23). Recent findings The Klotho gene encodes a single-pass transmembrane protein and functions as an aging-suppressor gene, which extends lifespan when overexpressed and accelerates the development of aging-like phenotypes when disrupted in mice. FGF23 is a bone-derived hormone that regulates phosphate and vitamin D metabolism. It has been shown that Klotho-deficient mice and FGF23 knockout mice exhibit identical phenotypes. This observation led to the identification of Klotho as a cofactor essential for the interaction between FGF23 and fibroblast growth factor receptors. In addition to the Klotho- FGF23 axis, recent studies have shown that βKlotho, a Klotho family protein, also functions as a cofactor required for FGF19 and FGF21 signaling and determines tissue-specific metabolic activities of FGF19 and FGF21. Recent mouse genetic studies have broadened our understanding of molecular pathways involved in mineral and bile acid homeostasis regulated by FGF23 and FGF19, respectively. The FGF19 subfamily of ligands requires the Klotho gene family of transmembrane proteins for their tissue-specific bioactivity. Further investigations on endocrine axes mediated by the Klotho family and FGF19 subfamily members are expected to provide new insights into the molecular mechanisms by which the endocrine fibroblast growth factors regulate bile acid, energy, and phosphate/vitamin D metabolism.

AB - Purpose of review This review summarizes recent progress in understanding of Klotho and βKlotho function in the regulation of tissue-specific metabolic activity of the endocrine fibroblast growth factors (FGF19, FGF21, and FGF23). Recent findings The Klotho gene encodes a single-pass transmembrane protein and functions as an aging-suppressor gene, which extends lifespan when overexpressed and accelerates the development of aging-like phenotypes when disrupted in mice. FGF23 is a bone-derived hormone that regulates phosphate and vitamin D metabolism. It has been shown that Klotho-deficient mice and FGF23 knockout mice exhibit identical phenotypes. This observation led to the identification of Klotho as a cofactor essential for the interaction between FGF23 and fibroblast growth factor receptors. In addition to the Klotho- FGF23 axis, recent studies have shown that βKlotho, a Klotho family protein, also functions as a cofactor required for FGF19 and FGF21 signaling and determines tissue-specific metabolic activities of FGF19 and FGF21. Recent mouse genetic studies have broadened our understanding of molecular pathways involved in mineral and bile acid homeostasis regulated by FGF23 and FGF19, respectively. The FGF19 subfamily of ligands requires the Klotho gene family of transmembrane proteins for their tissue-specific bioactivity. Further investigations on endocrine axes mediated by the Klotho family and FGF19 subfamily members are expected to provide new insights into the molecular mechanisms by which the endocrine fibroblast growth factors regulate bile acid, energy, and phosphate/vitamin D metabolism.

KW - ßKlotho

KW - FGF15

KW - FGF19

KW - FGF21

KW - FGF23

KW - Klotho

UR - http://www.scopus.com/inward/record.url?scp=55249119775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249119775&partnerID=8YFLogxK

U2 - 10.1097/MNH.0b013e3282ffd994

DO - 10.1097/MNH.0b013e3282ffd994

M3 - Article

C2 - 18660672

AN - SCOPUS:55249119775

VL - 17

SP - 368

EP - 372

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 4

ER -